Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma.
Cigliano A, Gigante I, Serra M, Vidili G, Simile MM, Steinmann S, Urigo F, Cossu E, Pes GM, Dore MP, Ribback S, Milia EP, Pizzuto E, Mancarella S, Che L, Pascale RM, Giannelli G, Evert M, Chen X, Calvisi DF. Cigliano A, et al. Among authors: urigo f. J Exp Clin Cancer Res. 2024 Sep 6;43(1):253. doi: 10.1186/s13046-024-03177-7. J Exp Clin Cancer Res. 2024. PMID: 39243039 Free PMC article.
FATP5 Is Indispensable for the Growth of Intrahepatic Cholangiocarcinoma.
Shihadih D, Wang X, Zushin PH, Khodakivskyi P, Park HM, Tso E, Shiblak J, Misic A, Louie SM, Ward C, Hellerstein M, Nomura DK, Goun E, Urigo F, Calvisi DF, Chen X, Stahl A. Shihadih D, et al. Among authors: urigo f. Mol Cancer Res. 2024 Jun 4;22(6):585-595. doi: 10.1158/1541-7786.MCR-23-0389. Mol Cancer Res. 2024. PMID: 38358323
Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates.
Córdoba KM, Jericó D, Jiang L, Collantes M, Alegre M, García-Ruiz L, Manzanilla O, Sampedro A, Herranz JM, Insausti I, Martinez de la Cuesta A, Urigo F, Alcaide P, Morán M, Martín MA, Lanciego JL, Lefebvre T, Gouya L, Quincoces G, Unzu C, Hervas-Stubbs S, Falcón-Pérez JM, Alegre E, Aldaz A, Fernández-Seara MA, Peñuelas I, Berraondo P, Martini PGV, Avila MA, Fontanellas A. Córdoba KM, et al. Among authors: urigo f. Gut. 2025 Jan 17;74(2):270-283. doi: 10.1136/gutjnl-2024-332619. Gut. 2025. PMID: 39366725 Free article.
Exploring current and emerging therapies for porphyrias.
Jericó D, Córdoba KM, Urigo F, Enríquez de Salamanca R, Anderson KE, Deybach JC, Ávila MA, Fontanellas A. Jericó D, et al. Among authors: urigo f. Liver Int. 2024 Sep;44(9):2174-2190. doi: 10.1111/liv.15979. Epub 2024 May 30. Liver Int. 2024. PMID: 38813953 Review.
31 results